Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Other 1Gastrointestinal 1Breast 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Rectal Neoplasms 1Anus Neoplasms 1

Interventions

fludarabine 5Cyclophosphamide 5aldesleukin 4Radiotherapy 3fludarabine phosphate 2entinostat 2aflibercept 2Vaccines 2Trastuzumab 2Radiation 2Papillomavirus Vaccines 2Nivolumab 2Adoptive Transfer 2trastuzumab deruxtecan 1tipifarnib 1rocakinogene sifuplasmid 1durvalumab 1bintrafusp alfa protein, human 1Watchful Waiting 1VGX-3100 1Surveys and Questionnaires 1Specimen Handling 1Ritonavir 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Octreotide 1Observation 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vaginal Neoplasms × Dehydroepiandrosterone × Gastrointestinal × Clear all
NCT07407647 2026-04-21

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
25 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡